Azizan A, Farhadi E, Faezi S, Jamshidi A, Alikhani M, Mahmoudi M
Immun Inflamm Dis. 2025; 13(2):e70124.
PMID: 39912562
PMC: 11800236.
DOI: 10.1002/iid3.70124.
Kaymaz S, Aydin D, Ugur K, Cobankara V, Tan S
Mediterr J Rheumatol. 2024; 35(2):255-262.
PMID: 39211027
PMC: 11350416.
DOI: 10.31138/mjr.030623.elc.
Antonova E, Hambikova A, Shcherbakov D, Sukhov V, Vysochanskaya S, Fadeeva I
Int J Mol Sci. 2023; 24(11).
PMID: 37298110
PMC: 10252288.
DOI: 10.3390/ijms24119160.
Hu Y, Li Q, Wang P, Li X, Hu Z
Front Oncol. 2023; 13:1140813.
PMID: 37182123
PMC: 10172652.
DOI: 10.3389/fonc.2023.1140813.
Steeman T, Weiner A, David A, Binolfi A, Calcaterra N, Armas P
Int J Mol Sci. 2023; 24(5).
PMID: 36902262
PMC: 10002522.
DOI: 10.3390/ijms24054828.
Circular RNA circLOC101928570 suppresses systemic lupus erythematosus progression by targeting the miR-150-5p/c-myb axis.
Zhao X, Dong R, Tang Z, Wang J, Wang C, Song Z
J Transl Med. 2022; 20(1):547.
PMID: 36435781
PMC: 9701435.
DOI: 10.1186/s12967-022-03748-2.
Investigation of Sperm and Seminal Plasma Candidate MicroRNAs of Bulls with Differing Fertility and In Silico Prediction of miRNA-mRNA Interaction Network of Reproductive Function.
Kasimanickam V, Kumar N, Kasimanickam R
Animals (Basel). 2022; 12(18).
PMID: 36139221
PMC: 9495167.
DOI: 10.3390/ani12182360.
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness.
Fan J, Wang S, Lu X, Sun Z
Metabolism. 2022; 134:155249.
PMID: 35792174
PMC: 9796492.
DOI: 10.1016/j.metabol.2022.155249.
The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Ziel-Swier L, Liu Y, Seitz A, de Jong D, Koerts J, Rutgers B
Genes (Basel). 2022; 13(2).
PMID: 35205272
PMC: 8871936.
DOI: 10.3390/genes13020227.
Functional and structural analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in the MYB oncoproteins associated with human cancer.
Lim S, Tan K, Azuraidi O, Sathiya M, Lim E, Lai K
Sci Rep. 2021; 11(1):24206.
PMID: 34921182
PMC: 8683427.
DOI: 10.1038/s41598-021-03624-x.
Inflamma-MicroRNAs in Alzheimer's Disease: From Disease Pathogenesis to Therapeutic Potentials.
Liang Y, Wang L
Front Cell Neurosci. 2021; 15:785433.
PMID: 34776873
PMC: 8581643.
DOI: 10.3389/fncel.2021.785433.
The Role of microRNAs in Pulp Inflammation.
Munoz-Carrillo J, Vazquez-Alcaraz S, Vargas-Barbosa J, Ramos-Gracia L, Alvarez-Barreto I, Medina-Quiroz A
Cells. 2021; 10(8).
PMID: 34440911
PMC: 8391605.
DOI: 10.3390/cells10082142.
Gene regulatory networks controlling vertebrate retinal regeneration.
Hoang T, Wang J, Boyd P, Wang F, Santiago C, Jiang L
Science. 2020; 370(6519).
PMID: 33004674
PMC: 7899183.
DOI: 10.1126/science.abb8598.
miR-150 regulates endothelial progenitor cell differentiation via Akt and promotes thrombus resolution.
Du X, Hu N, Yu H, Hong L, Ran F, Huang D
Stem Cell Res Ther. 2020; 11(1):354.
PMID: 32787969
PMC: 7425584.
DOI: 10.1186/s13287-020-01871-9.
MicroRNA-150 Modulates Adipogenic Differentiation of Adipose-Derived Stem Cells by Targeting Notch3.
Li X, Zhao Y, Li X, Wang Q, Ao Q, Wang X
Stem Cells Int. 2019; 2019:2743047.
PMID: 31781236
PMC: 6875317.
DOI: 10.1155/2019/2743047.
DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.
Hu T, Chong Y, Cai B, Liu Y, Lu S, Cowell J
J Biol Chem. 2019; 294(48):18122-18130.
PMID: 31628193
PMC: 6885633.
DOI: 10.1074/jbc.RA119.010144.
MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
Tung C, Kuo L, Huang M, Wu Y, Tsai Y, Wu J
Oncogene. 2019; 39(4):862-876.
PMID: 31570789
DOI: 10.1038/s41388-019-1025-x.
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
Wefers A, Stichel D, Schrimpf D, Coras R, Pages M, Tauziede-Espariat A
Acta Neuropathol. 2019; 139(1):193-209.
PMID: 31563982
PMC: 7477753.
DOI: 10.1007/s00401-019-02078-w.
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Srutova K, Curik N, Burda P, Savvulidi F, Silvestri G, Trotta R
Haematologica. 2018; 103(12):2016-2025.
PMID: 30049824
PMC: 6269310.
DOI: 10.3324/haematol.2018.193086.
MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.
Yang Y, Alderman C, Sehlaoui A, Xiao Y, Wang W
Can J Gastroenterol Hepatol. 2018; 2018:9740357.
PMID: 30046565
PMC: 6038585.
DOI: 10.1155/2018/9740357.